Northwestern Mutual Wealth Management Co. Makes New $4.38 Million Investment in Corteva, Inc. $CTVA

Northwestern Mutual Wealth Management Co. acquired a new stake in shares of Corteva, Inc. (NYSE:CTVA) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 51,728 shares of the company’s stock, valued at approximately $4,381,000.

A number of other hedge funds have also recently modified their holdings of CTVA. Vanguard Group Inc. grew its position in shares of Corteva by 0.4% in the 4th quarter. Vanguard Group Inc. now owns 80,536,951 shares of the company’s stock worth $5,398,392,000 after buying an additional 317,538 shares during the period. BlackRock Inc. purchased a new position in Corteva during the 2nd quarter valued at about $4,560,180,000. State Street Corp lifted its position in Corteva by 3.7% during the 4th quarter. State Street Corp now owns 36,570,876 shares of the company’s stock valued at $2,451,346,000 after acquiring an additional 1,290,071 shares during the period. Franklin Resources Inc. boosted its stake in Corteva by 4.3% during the fourth quarter. Franklin Resources Inc. now owns 19,537,500 shares of the company’s stock worth $1,309,599,000 after acquiring an additional 805,873 shares in the last quarter. Finally, Harris Associates L P boosted its stake in Corteva by 168.1% during the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock worth $1,141,268,000 after acquiring an additional 10,675,052 shares in the last quarter. Institutional investors own 81.54% of the company’s stock.

Corteva Price Performance

NYSE CTVA opened at $81.84 on Monday. Corteva, Inc. has a one year low of $60.53 and a one year high of $90.97. The stock has a 50-day moving average of $82.13 and a 200 day moving average of $80.26. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52. The company has a market capitalization of $54.60 billion, a price-to-earnings ratio of 54.20, a PEG ratio of 2.51 and a beta of 0.57.

Corteva (NYSE:CTVA) last posted its earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.24 by $0.06. The business had revenue of $6.38 billion for the quarter, compared to analysts’ expectations of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The business’s revenue for the quarter was down 1.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, sell-side analysts forecast that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be given a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio is 47.68%.

Wall Street Analysts Forecast Growth

CTVA has been the subject of a number of analyst reports. Citigroup raised their target price on shares of Corteva from $85.00 to $86.00 and gave the company a “neutral” rating in a research note on Monday, August 3rd. Oppenheimer boosted their price target on Corteva from $89.00 to $95.00 and gave the stock an “outperform” rating in a research report on Thursday, July 23rd. BMO Capital Markets upped their price target on Corteva from $95.00 to $100.00 and gave the stock an “outperform” rating in a research note on Monday, August 3rd. BNP Paribas Exane raised their price objective on Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. Finally, Mizuho lifted their price objective on Corteva from $96.00 to $97.00 and gave the company an “outperform” rating in a research note on Tuesday, July 14th. Fourteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat, Corteva has a consensus rating of “Moderate Buy” and an average target price of $91.50.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.